Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05964088 · ClinicalTrials.gov registry record
Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients
A clinical trial, sponsored by Arrowhead Regional Medical Center.
- Completed
- Registry status
- 267
- Enrollment target
NCT05964088 is a clinical trial that has completed, run by Arrowhead Regional Medical Center. The registered enrollment target is 267 participants.
The verdict
NCT05964088 has completed, sponsored by Arrowhead Regional Medical Center.
- COMPLETED
- Registry status
- 267 participants
- Enrollment target
Study Summary
This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients were initially managed on the medical floor and later transferred to the ICU for worsening respiratory status. The investigating team evaluated the correlation of inflammatory markers and common risk factors such as obesity, diabetes, hypertension and ethnicity to the development of AKI in the target population. The primary outcome is mortality participants will received their regular healthcare in a medical setting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2022-02-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05964088
The ClinicalTrials.gov registry entry for NCT05964088 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 267 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arrowhead Regional Medical Center, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05964088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05964088 about?
NCT05964088 is a clinical study titled "Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients". This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients...
What is the current status of trial NCT05964088?
This trial is currently completed. The enrollment target is 267 participants. The study started on 2020-03-01. Estimated completion is 2022-02-12.
Who is sponsoring clinical trial NCT05964088?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.